Professional Documents
Culture Documents
HBR Cases For Evaluation I of Product Management
HBR Cases For Evaluation I of Product Management
HBR Cases For Evaluation I of Product Management
Maximum Marks: 30
Division B:
Group 1 – Q1 to Q5
Group 2 – Q6 to Q9
Group 3 – Q1 to Q5
Group 4 – Q6 to Q9
Group 5
III. Glaxo and Zantac: The Life, Times, and Near Death of the World's Best-Selling Drug
(2)
1. Management books often talk of a first mover advantage for an innovator? What advantages
did SmithKline have by being first to market an H2 Antagonist?
2. How well did SmithKline capitalise on these advantages?
3. Was Zantac a better product than Tagamet?
4. Why was Zantac able to take market leadership from Tagamet?
5. What are the key lessons to takeaway from examining the rise to the status of best-selling
drug of all time and subsequent fall to insignificance?
6. Which one is a better product Zantac or Tagamet?
Group 6
Group 7
Group 8
Group 9
VII. Coca-Cola India: More than Just Sugar and Fizz (2)
1. Analyse Coca Cola brand and the reasons for it’s branding success over the years?
2. How did Coca Cola Company create value among it’s customers?
3. How has Coca Cola’s understanding of Consumer Behavior helped shape it’s marketing
strategies?
4. Which categories should Coca Cola consider entering into or expanding within to become a
total beverage company, and why?
5. Which of it’s international brands should Coca Cola launch in India?
6. Which brands can be leveraged with brand extensions?
Group 10
Group 11